Elekta Chosen by Five UK Hospitals in NHS Investment Wave.STOCKHOLM, Sweden -- Elekta, a world leader in advanced radiation therapy, comprehensive cancer management and non-invasive treatment of brain disorders, today announced a resounding re·sound v. re·sound·ed, re·sound·ing, re·sounds v.intr. 1. To be filled with sound; reverberate: The schoolyard resounded with the laughter of children. 2. success, winning all tenders entered, in the ninth 'wave' of National Health Service (NHS NHS abbr. National Health Service NHS (in Britain) National Health Service ) investments under the ongoing plan to improve treatment capacity in the fight against cancer in the United Kingdom. As a part of the country's national cancer program, United Kingdom is currently investing in increased capacity for radiation treatment of cancer. These investments are sponsored by the Department of Health, providing the funding, which is applied for by the NHS Hospitals and released in so-called 'waves'. Recently, the awarded tenders in the ninth of these waves were announced. Winning all competitive tenders entered, Elekta will deliver six advanced digital linear accelerators for radiation therapy to five UK hospitals. In total, these orders are valued at over GBP GBP In currencies, this is the abbreviation for the British Pound. Notes: The currency market, also known as the Foreign Exchange market, is the largest financial market in the world, with a daily average volume of over US $1 trillion. 6 million and were order booked by Elekta in April. All five hospitals opting for Elekta Synergy(R) Elekta was chosen following a competitive and in-depth selection process facilitated by the NHS Trust National Health Service Trusts (NHS Trusts) provide many services of the National Health Service in England and Wales. They are not trusts in the legal sense but are in effect public sector corporations. and the orders from Guy's Hospital in London, New Cross Hospital in Wolverhampton, Queen Elizabeth Hospital Queen Elizabeth Hospital can refer to one of several hospitals named after either Elizabeth II of the United Kingdom or Queen Elizabeth the Queen Mother: Australia
"At Elekta, we are proud to be a partner to UK health care in the quest to improve quality and capacity in cancer care", says David Miles, Managing Director for Elekta's Business Unit UK & Ireland, and continues; "It is particularly pleasing that all hospitals opted for our solution for advanced, three-dimensional IGRT, a cost-effective technology that is set to greatly enhance accuracy and precision in radiation therapy and thereby improve quality of care for British cancer patients." Information management systems from IMPAC IMPAC International Merchant Purchase Authorization Card IMPAC Intersegmental Major Preparation Articulated Curriculum IMPAC Information for Management, Planning, Analysis, and Coordination (National Institutes of Health) In addition to choosing Elekta's clinical solutions, three of the hospitals have also chosen to install information management systems from IMPAC Medical Systems, an Elekta company. These image guided treatment management (IGTM IGTM International Golf Travel Market (TM)) systems will connect treatment planning systems, imaging systems and the radiation therapy delivery equipment - regardless of manufacturer - in order to reduce cost, smooth the patient flow and provide seamless connectivity to the systems and devices that are integral to the full spectrum of cancer care. "The result of this 'wave' is yet another proof of Elekta's strength in Europe, a market that has now clearly regained momentum", says Olof Sanden, Regional Vice President and head of Elekta's Sales and Marketing in Europe. "The fact that all hospitals chose Elekta Synergy, shows the increased acceptance of 3D IGRT solutions. Only with the full 3D imaging capability will clinicians get the full advantage of IGRT and Elekta has clearly set the standard for this exciting development", Olof Sanden concludes. About Elekta Elekta is an international medical-technology Group, providing meaningful clinical solutions, comprehensive information systems and services for improved cancer care and management of brain disorders. All of Elekta's solutions employ non-invasive or minimally invasive techniques and are therefore clinically effective, gentle on the patient and cost-effective. Clinical solutions include among others Leksell Gamma Knife Gamma Knife A trademark for a radiologic nonsurgical device used in stereotactic radiosurgery. Gamma knife A surgical tool that focuses beams of radiation at the head, which converge in the brain to form a lesion. (R) for non-invasive treatment of brain disorders and Elekta Synergy(R) for image guided radiation therapy (IGRT). Following the acquisition of IMPAC Medical Systems Inc. in April 2005, the Elekta Group is the world's largest supplier of oncology software. Elekta's systems and solutions are used at over 3,000 hospitals around the world to treat cancer and manage clinical operations as well as to diagnose and treat brain disorders, including tumors, vascular malformations and functional disorders. With approx. 1800 employees, Elekta's corporate headquarter head·quar·ter v. head·quar·tered, head·quar·ter·ing, head·quar·ters Usage Problem v.tr. To provide with headquarters: is located in Stockholm, Sweden and the company is listed on the Stockholm Stock Exchange The Stockholm Stock Exchange (Swedish: Stockholmsbörsen) is a stock exchange located in Stockholm, Sweden. Founded in 1863 [1] it is the primary securities exchange of the Nordic Countries. under the ticker EKTAb. For more information about Elekta, please visit www.elekta.com. This information was brought to you by Waymaker http://www.waymaker.net |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion